Universal Influenza B Virus Genomic Amplification Facilitates Sequencing, Diagnostics, and Reverse Genetics

Influenza-associated mortality in temperate and subtropical Chinese cities, 2003–2008

(2014) Luzhao Feng et al.   BULLETIN OF THE WORLD HEALTH ORGANIZATION

Asparagine Substitution at PB2 Residue 701 Enhances the Replication, Pathogenicity, and Transmission of the 2009 Pandemic H1N1 Influenza A Virus

(2013) Bin Zhou et al.   PLoS One

Influenza Research Database: an integrated bioinformatics resource for influenza research and surveillance

(2012) R. Burke Squires et al.   Influenza and Other Respiratory Viruses

Engineering temperature sensitive live attenuated influenza vaccines from emerging viruses

(2012) Bin Zhou et al.   VACCINE

The rationale for quadrivalent influenza vaccines

(2012) Christopher S. Ambrose et al.   Human Vaccines & Immunotherapeutics

Molecular studies of influenza B virus in the reverse genetics era

(2010) D. Jackson et al.   JOURNAL OF GENERAL VIROLOGY

PB2 Residue 158 Is a Pathogenic Determinant of Pandemic H1N1 and H5 Influenza A Viruses in Mice

(2010) B. Zhou et al.   JOURNAL OF VIROLOGY

In-Fusion BioBrick assembly and re-engineering

(2010) Sean C. Sleight et al.   NUCLEIC ACIDS RESEARCH

Single-Reaction Genomic Amplification Accelerates Sequencing and Vaccine Production for Classical and Swine Origin Human Influenza A Viruses

(2009) B. Zhou et al.   JOURNAL OF VIROLOGY